These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 5834736

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Separate and sequential chemotherapy of mouse leukemia L1210 with 1-beta-D-arabinofuranosylcytosine hydrochloride and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Tyrer DD, Kline I, Venditti JM, Goldin A.
    Cancer Res; 1967 May; 27(5):873-9. PubMed ID: 6025252
    [No Abstract] [Full Text] [Related]

  • 4. Value of cytosine arabinoside (NSC-63878) plus 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) therapy in advanced murine L1210 leukemia and enhancement of the combination with sequential doses of methotrexate (NSC-740) or 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
    Kline I, Woodman RJ, Gang M, Cysyk RL, Venditti JM.
    Cancer Chemother Rep; 1973 May; 57(3):291-8. PubMed ID: 4751255
    [No Abstract] [Full Text] [Related]

  • 5. Effect of treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or cyclophosphamide on spleen colony-forming units and survival time of leukemic mice.
    Vadlamudi S, Waravdekar VS, Choudry JN, Goldin A.
    Cancer Res; 1968 Jul; 28(7):1242-9. PubMed ID: 5665982
    [No Abstract] [Full Text] [Related]

  • 6. Criteria associated with destruction of leukemia and solid tumor cells in animals.
    Skipper HE.
    Cancer Res; 1967 Dec; 27(12):2636-45. PubMed ID: 6082300
    [No Abstract] [Full Text] [Related]

  • 7. Effects of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) and its degradation products on progression of L1210 cells through the cell cycle.
    Bray DA, DeVita VT, Adamson RH, Oliverio VT.
    Cancer Chemother Rep; 1971 Jun; 55(3):215-20. PubMed ID: 5115843
    [No Abstract] [Full Text] [Related]

  • 8. Effect of 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and cyclophosphamide (NSC-26271) on nicotinamide adenine dinucleotide glycohydrolase in normal and leukemic mouse tissues.
    Tsukagoshi S, Kao MH, Goldin A.
    Cancer Chemother Rep; 1968 Sep; 52(5):569-78. PubMed ID: 5743704
    [No Abstract] [Full Text] [Related]

  • 9. Enhancement of the antitumor effect of 1,3-bis(2-chloroethyl)-1-nitrosourea by vitamin A and caffeine.
    Cohen MH.
    J Natl Cancer Inst; 1972 Apr; 48(4):927-32. PubMed ID: 5023690
    [No Abstract] [Full Text] [Related]

  • 10. 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer.
    van Eden EB, Falkson HC, Falkson G.
    Cancer Chemother Rep; 1970 Oct; 54(5):347-59. PubMed ID: 5514624
    [No Abstract] [Full Text] [Related]

  • 11. Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors.
    Kinne DW, Humphrey EW.
    Cancer Chemother Rep; 1972 Feb; 56(1):53-9. PubMed ID: 5030809
    [No Abstract] [Full Text] [Related]

  • 12. Immunological alteration of leukemic cells in vivo after treatment with an antitumor drug.
    Bonmassar E, Bonmassar A, Vadlamudi S, Goldin A.
    Proc Natl Acad Sci U S A; 1970 Aug; 66(4):1089-95. PubMed ID: 5273445
    [Abstract] [Full Text] [Related]

  • 13. Studies on the chemotherapy of experimental brain tumors: evaluation of 1,3-bis(2-chloroethyl)-l-nitrosourea, cyclophosphamide, mithramycin, and methotrexate.
    Shapiro WR, Ausman JI, Rall DP.
    Cancer Res; 1970 Sep; 30(9):2401-13. PubMed ID: 5475484
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Nitrosoureas: 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962; BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC-79037; CCNU)--clinical brochure.
    Carter SK, Newman JW.
    Cancer Chemother Rep 3; 1968 Dec; 1(1):115-51. PubMed ID: 4917773
    [No Abstract] [Full Text] [Related]

  • 16. The effect of chemotherapy on the growth characteristics and cellular kinetics of leukemia L1210.
    Young RC, DeVita VT.
    Cancer Res; 1970 Jun; 30(6):1789-94. PubMed ID: 5457940
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) in the management of patients with advanced breast cancer.
    Ahmann DL, Hahn RG, Bisel HF.
    Cancer Chemother Rep; 1972 Feb; 56(1):93-4. PubMed ID: 5030810
    [No Abstract] [Full Text] [Related]

  • 18. 5-Fluorouracil (5-Fu; NSC-19893), 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388), vincristine (NSC-67574), and 1,3-bis(2-chloroethyl)-2-nitrosourea (BCNU; NSC-409962) given concomitantly in the treatment of solid tumors in man.
    van Eden EB, Falkson G, van Dyk JJ, van der Merwe AM, Falkson HC.
    Cancer Chemother Rep; 1972 Feb; 56(1):107-47. PubMed ID: 5030803
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. X.
    Kline I, Gang M, Tyrer DD, Venditti JM, Artis EW, Goldin A.
    Cancer Chemother Rep 2; 1972 Nov; 3(1):1-69. PubMed ID: 4660732
    [No Abstract] [Full Text] [Related]

  • 20. Sequential 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037) and 5-fluorouracil (NSC 19893) therapy of gastrointestinal cancer.
    Moertel CG, Schutt AJ, Reitemeier RJ, Hahn RG.
    Cancer Res; 1972 Jun; 32(6):1280-2. PubMed ID: 5030827
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.